Our panel of colorectal cancer lines includes some lines with reported intact cGAS/STING signaling (HT-29, LoVo, CT26) and some with reported cGAS deficiency (HCT116, Ls174T, and SW1417; refs. 38, 39). This evidence concerns the gene CGAS and colorectal cancer.